• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE® TAG®THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE® TAG®THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGU262110
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aneurysm (1708)
Event Date 07/14/2021
Event Type  Injury  
Event Description
On (b)(6), 2011 this patient underwent endovascular treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.The devices were implanted to create an aorto-uni-iliac configuration.On (b)(6) 2021, during follow up, it was discovered that the device had migrated distally, and a type i proximal endoleak as present.On (b)(6) 2021 a reintervention occurred whereby a contralateral leg component was implanted 4cm distal to the lowest renal artery, and a trunk-ipsilateral leg endoprosthesis was implanted at the level of the lowest renal artery.The endoleak was resolved and the patient tolerated the procedure.
 
Event Description
On (b)(6) 2011, this patient underwent endovascular treatment of an abdominal aortic aneurysm using a conformable gore® tag® thoracic endoprosthesis (ctag) and a gore® excluder® aaa endoprosthesis contralateral leg component.The devices were implanted to create an aorto-uni-iliac configuration.On (b)(6) 2021, during follow up, it was discovered that the ctag device had migrated distally, and a type i proximal endoleak was present.On (b)(6) 2021, a reintervention occurred whereby a contralateral leg component was implanted 4cm distal to the lowest renal artery, and a trunk-ipsilateral leg endoprosthesis was implanted at the level of the lowest renal artery.The endoleak was resolved and the patient tolerated the procedure.
 
Manufacturer Narrative
H10/11: corrected data - b4: description of event (initial report indicated that patient was treated with a gore® excluder® aaa endoprosthesis only.Corrected description to indicate patient was treated with a conformable gore® tag® thoracic endoprosthesis (ctag) and a gore® excluder® aaa endoprosthesis contralateral leg component to create an aui.
 
Manufacturer Narrative
Investigation findings and investigation conclusion codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONFORMABLE GORE® TAG®THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
douglas rhodes
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13118173
MDR Text Key283441149
Report Number2017233-2021-02650
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132617791
UDI-Public00733132617791
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 01/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2014
Device Model NumberTGU262110
Device Catalogue NumberTGU262110
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/08/2021
Initial Date FDA Received12/30/2021
Supplement Dates Manufacturer Received12/08/2021
12/08/2021
Supplement Dates FDA Received01/19/2022
01/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/23/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient SexMale
-
-